Skip to content
Search

Latest Stories

DHSC publishes guidance for contractors to access extra flu vaccines

The Department of Health and Social Care (DHSC) has published guidance for community pharmacy contractors to access supplies of flu vaccines procured centrally by the government.

After the success of the seasonal flu immunization programme last year, which resulted in a record uptake of flu vaccines, the DHSC aims to “achieve even higher vaccine uptake rates compared to last year,” it said, in guidance published last week.


DHSC has secured an additional supply of influenza vaccines, as a temporary measure for this year only. The vaccines stocks will be available for NHS trusts, general practices and community pharmacies, to replenish local supplies once they run low.

These stocks will be deployed to areas where it is most needed to maximize the uptake.

Moreover, to keep the process easy and quick, DHSC has kept the same supply route through which pharmacies normally receive their flu vaccines.

Contact wholesalers

The additional stocks will arrive in November, and DHSC will sell some of their centrally procured stock to the pharmacy wholesalers, for further sale to pharmacy contractors.

Community pharmacies should contact their wholesaler for details on what stock is available,” the guidance said.

It specified that it has ordered additional stocks of QIVc, QIVe and QIVr to boost supply.

DHSC has also advised contractors to assess the need for more flu vaccine by analysing the uptake rates in eligible cohorts.

To order more contractors should “contact their regular wholesaler to access additional stock and follow the wholesaler’s process for ordering stock”.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less